FDA Workshop To Discuss Brain Tumor Trial Endpoints
This article was originally published in The Pink Sheet Daily
Executive SummaryThe Jan. 20 public meeting is next in a series of meetings on oncology endpoints.
You may also be interested in...
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.